On June 5, 2025, Moleculin Biotech, Inc. hosted a Virtual Key Opinion Leaders event focusing on Soft Tissue Sarcoma Lung Mets, where experts were compensated for their participation. This event aims to showcase their developments in the field but does not include any significant financial impacts.